ATE454444T1 - Verfahren zur herstellung rekombinanter proteine - Google Patents

Verfahren zur herstellung rekombinanter proteine

Info

Publication number
ATE454444T1
ATE454444T1 AT04768294T AT04768294T ATE454444T1 AT E454444 T1 ATE454444 T1 AT E454444T1 AT 04768294 T AT04768294 T AT 04768294T AT 04768294 T AT04768294 T AT 04768294T AT E454444 T1 ATE454444 T1 AT E454444T1
Authority
AT
Austria
Prior art keywords
recombinant protein
coli host
periplasm
growth rate
host cell
Prior art date
Application number
AT04768294T
Other languages
English (en)
Inventor
David John Glover
Mukesh Sehdev
Dominic Gambier Reeks
Original Assignee
Ucb Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29226759&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE454444(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa
Application granted granted Critical
Publication of ATE454444T1 publication Critical patent/ATE454444T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Jellies, Jams, And Syrups (AREA)
AT04768294T 2003-09-09 2004-09-02 Verfahren zur herstellung rekombinanter proteine ATE454444T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0321100.0A GB0321100D0 (en) 2003-09-09 2003-09-09 Biological products
PCT/GB2004/003747 WO2005024000A1 (en) 2003-09-09 2004-09-02 Methods for producing recombinant proteins

Publications (1)

Publication Number Publication Date
ATE454444T1 true ATE454444T1 (de) 2010-01-15

Family

ID=29226759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04768294T ATE454444T1 (de) 2003-09-09 2004-09-02 Verfahren zur herstellung rekombinanter proteine

Country Status (20)

Country Link
US (2) USRE44512E1 (de)
EP (1) EP1664278B1 (de)
JP (1) JP4568722B2 (de)
KR (1) KR20060125704A (de)
CN (1) CN1849389B (de)
AT (1) ATE454444T1 (de)
AU (1) AU2004270929B2 (de)
BR (1) BRPI0413813A (de)
CA (1) CA2536099C (de)
DE (1) DE602004025011D1 (de)
EA (1) EA200600554A1 (de)
ES (1) ES2339352T3 (de)
GB (1) GB0321100D0 (de)
IL (1) IL173474A0 (de)
MX (1) MXPA06002589A (de)
NO (1) NO20061576L (de)
PL (1) PL1664278T3 (de)
SG (1) SG145696A1 (de)
WO (1) WO2005024000A1 (de)
ZA (1) ZA200601177B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2608579C (en) * 2005-05-26 2019-09-10 Cytos Biotechnology Ag Scalable fermentation process
SI2493922T1 (sl) 2009-10-26 2017-06-30 F. Hoffmann-La Roche Ag Postopek za proizvodnjo glikoziliranega imunoglobulina
ES3011307T3 (en) 2012-02-23 2025-04-07 Juno Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
DK2825633T3 (da) * 2012-03-12 2019-05-20 Hanmi Science Co Ltd Fremgangsmåde til dyrkning af E. coli-celler til høj densitet
EA201791982A1 (ru) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
EP3365453A2 (de) 2015-10-22 2018-08-29 Juno Therapeutics GmbH Verfahren, kits, mittel und vorrichtungen zur transduktion
MX2018004875A (es) 2015-10-22 2018-08-01 Juno Therapeutics Gmbh Metodos para cultivar celulas y kits y aparatos para ello.
EP3436610A1 (de) 2016-03-29 2019-02-06 Geltor, Inc. Expression von proteinen in gramnegativen bakterien mit verhältnis von periplasmatischem volumen zu zytoplasmatischem volumen zwischen 0,5:1 und 10:1
JP2020515639A (ja) 2017-04-03 2020-05-28 コヒラス・バイオサイエンシズ・インコーポレイテッド 進行性核上性麻痺の処置のためのＰＰＡＲγアゴニスト
JP7339160B2 (ja) 2017-04-27 2023-09-05 ジュノ セラピューティクス ゲーエムベーハー オリゴマー粒子試薬およびその使用方法
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
SG11202104355SA (en) 2018-10-31 2021-05-28 Juno Therapeutics Gmbh Methods for selection and stimulation of cells and apparatus for same
WO2020118043A1 (en) 2018-12-07 2020-06-11 Coherus Biosciences, Inc. Methods for producing recombinant proteins
EP3953380A4 (de) 2019-04-12 2023-01-25 Geltor, Inc. Rekombinantes elastin und herstellung davon
WO2021072182A1 (en) 2019-10-11 2021-04-15 Coherus Biosciences, Inc. Methods for producing ranibizumab
WO2021072210A1 (en) 2019-10-11 2021-04-15 Coherus Biosciences, Inc. Methods of purifying ranibizumab or a ranibizumab variant
CN113355264B (zh) * 2021-06-28 2022-03-08 山东智汇达海洋生物科技有限公司 一株产甘油的嗜高温菌及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0335567A3 (de) 1988-03-30 1990-11-14 Biogen, Inc. Kontrollierte Freisetzung periplasmatischer Proteine in das Medium
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
CA2090126C (en) 1990-08-02 2002-10-22 John W. Schrader Methods for the production of proteins with a desired function
GB9215540D0 (en) * 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
DK1332222T3 (da) * 2000-11-03 2009-07-06 Genentech Inc Stofskifteændringer i fermenteringer der udtrykker rekombinante proteiner
DE602004004796T2 (de) 2003-08-13 2007-12-06 Sandoz Ag Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide

Also Published As

Publication number Publication date
EP1664278A1 (de) 2006-06-07
CA2536099A1 (en) 2005-03-17
KR20060125704A (ko) 2006-12-06
BRPI0413813A (pt) 2006-10-17
USRE44512E1 (en) 2013-10-01
CA2536099C (en) 2015-11-17
ES2339352T3 (es) 2010-05-19
SG145696A1 (en) 2008-09-29
AU2004270929B2 (en) 2010-01-21
US20080044817A1 (en) 2008-02-21
JP2007504815A (ja) 2007-03-08
EA200600554A1 (ru) 2006-08-25
US7754447B2 (en) 2010-07-13
PL1664278T3 (pl) 2010-06-30
MXPA06002589A (es) 2006-06-05
IL173474A0 (en) 2006-06-11
WO2005024000A1 (en) 2005-03-17
EP1664278B1 (de) 2010-01-06
NO20061576L (no) 2006-04-07
AU2004270929A1 (en) 2005-03-17
JP4568722B2 (ja) 2010-10-27
ZA200601177B (en) 2007-04-25
CN1849389A (zh) 2006-10-18
DE602004025011D1 (de) 2010-02-25
CN1849389B (zh) 2012-05-23
GB0321100D0 (en) 2003-10-08

Similar Documents

Publication Publication Date Title
ATE454444T1 (de) Verfahren zur herstellung rekombinanter proteine
WO2023049742A3 (en) Engineered casx repressor systems
DE502004008542D1 (de) Verfahren zur reklonierung von produktionszellen
CY1110494T1 (el) Μεταστροφες μεταβολικου ρυθμου σε ζυμωσεις που εκφραζουν ανασυνδυασμενες πρωτεϊνες
ATE421994T1 (de) Genexpressionsmethode
ATE374828T1 (de) Expressionsvektor zur antibiotikafreien expression
WO2002099067A3 (en) Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
DE502007005530D1 (de) Mikroorganismenstamm zur Produktion von rekombinanten Proteinen
ATE512230T1 (de) Proteinherstellungsverfahren unter nutzung von yebf
GB2429211A (en) Feeder independent extended culture of embryonic stem cells
Viader‐Salvadó et al. Shrimp (Litopenaeus vannamei) trypsinogen production in Pichia pastoris bioreactor cultures
ATE493503T1 (de) Verfahren zur fermentativen herstellung von proteinen
ATE312939T1 (de) Verfahren zur rekombinanten herstellung von polypeptiden
DE60219361D1 (de) Verfahren zur rekombinanten herstellung von plazenta wachstumsfaktor
ATE494367T1 (de) Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität
CN102286518B (zh) 构建严谨型t7表达系统宿主菌的方法
WO2005045045A3 (en) Recombinant microorganism
WO2004046359A3 (en) Method of controlling gene expression in plants or plant cells
SE9904247D0 (sv) Compositions and methods utilizing sequences for controlling nucleic acid expression in yeast
EP1721976A4 (de) Modifizierter promotor
Donpromma et al. Production of recombinant bone morphogenetic protein‐2 in Escherichia coli: process optimization in shake flask and bioreactor cultures using statistical experimental design
DE602004029868D1 (de) Verfahren zur herstellung eines heterologen proteins in e. coli
ATE429446T1 (de) Recombinante igf expressionssysteme
ATE381576T1 (de) Verfahren zur aufreinigung eines n-terminalen fragments des hepatozytenwachstumsfaktors
JO2429B1 (en) Ways to produce recombinant peptides of antigen - merger

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties